[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @plustxinc Plus Therapeutics (Nasdaq: PSTV) Plus Therapeutics recently announced a national coverage agreement with UnitedHealthcare, covering over XX million people in the US, for its CNSide cerebrospinal fluid tumor cell enumeration laboratory-developed test. This agreement is a significant development for the company's diagnostic test for leptomeningeal metastases. The company's CEO, Marc Hedrick, has been discussing this agreement in recent interviews. ### Engagements: XXX [#](/creator/twitter::1130985137389297664/interactions)  - X Week XXXXX -XX% - X Month XXXXXXXXX +4,106% - X Months XXXXXXXXX +160,917% - X Year XXXXXXXXX +104,507% ### Mentions: X [#](/creator/twitter::1130985137389297664/posts_active)  - X Month X -XX% - X Months XX +417% - X Year XX +85% ### Followers: XXXXX [#](/creator/twitter::1130985137389297664/followers)  - X Week XXXXX +0.99% - X Month XXXXX +3.20% - X Months XXXXX +100% - X Year XXXXX +139% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1130985137389297664/influencer_rank)  ### Social Influence **Social category influence** [exchanges](/list/exchanges) #2658 **Social topic influence** [$pstv](/topic/$pstv) #2, [$pstvs](/topic/$pstvs) #1, [ceo](/topic/ceo) 25%, [pstv](/topic/pstv) 12.5%, [san antonio](/topic/san-antonio) 12.5%, [poster](/topic/poster) 12.5%, [abstract](/topic/abstract) 12.5%, [marc](/topic/marc) 12.5%, [$6753t](/topic/$6753t) 12.5%, [build a](/topic/build-a) XXXX% **Top accounts mentioned or mentioned by** [@cnsidedx](/creator/undefined) [@uthealthsa](/creator/undefined) [@stocktwits](/creator/undefined) [@sabcssanantonio](/creator/undefined) [@katieeperry](/creator/undefined) [@humana](/creator/undefined) [@uhc](/creator/undefined) [@usfda](/creator/undefined) [@irat1onal](/creator/undefined) [@progresspotent1](/creator/undefined) [@neurooncs](/creator/undefined) [@onlyxrp](/creator/undefined) [@matt034291601](/creator/undefined) [@billcoconsult](/creator/undefined) ### Top Social Posts Top posts by engagements in the last XX hours "$PSTV's President and CEO Marc Hedrick MD recently spoke with @Stocktwits' @katieeperry on how #PSTV is harnessing the power of @CNSideDx to provide actionable insights for #oncology patients through highly personalized and effective treatment strategies. Dr. Hedrick discusses the capabilities of REYOBIQ in the ReSPECT #clinicaltrials and #CNSideDiagnostics' capabilities including our recent coverage partnerships with @Humana and @UHC goals to expand this coverage even further and more. Learn more about #CNSide here: Learn more about REYOBIQ here: Check out the full interview below:" [X Link](https://x.com/plustxinc/status/1995604451886031060) 2025-12-01T21:22Z 1526 followers, 3585 engagements "$PSTV announces that it has been granted lab licenses to provide the #CNSide Cerebrospinal Fluid Tumor Cell Enumeration lab developed test in California Rhode Island and Maryland. Full press release: Learn more about @CNSideDx:" [X Link](https://x.com/plustxinc/status/1999099393463791745) 2025-12-11T12:50Z 1526 followers, 2981 engagements "$PSTV announced it has completed a Type B meeting with the announced it has completed a Type B meeting with the @US_FDA to discuss its REYOBIQ clinical development plans for #leptomeningealmetastases including the design of a planned ReSPECT-LM pivotal or registrational trial. Read more here: About the ReSPECT-LM trial: #ClinicalTrial #PSTV #ClinicalTrials" [X Link](https://x.com/plustxinc/status/1992936979873292712) 2025-11-24T12:42Z 1527 followers, 7142 engagements "$PSTV announces the acceptance of an abstract for poster spotlight (with oral) presentation at the upcoming San Antonio Breast Cancer Symposium (#SABCS25) being held on December 9-12 2025 in San Antonio TX. Full press release here: @SABCSSanAntonio #SABCS @UTHealthSA" [X Link](https://x.com/plustxinc/status/1995484146576322655) 2025-12-01T13:24Z 1527 followers, 2365 engagements "#PlusTherapeutics momentum in central nervous system (CNS) oncology was highlighted when our President & CEO Marc Hedrick MD recently sat down with @irat1onal on the @ProgressPotent1 podcast. The discussion is a sharp look at where $PSTV is headed as we build a differentiated position in CNS #oncology. In under an hour Dr. Hedrick breaks down: - Why #leptomeningealmetastases (LM) and recurrent #glioblastoma (#GBM) represent some of the clearest opportunities for targeted #radiotherapeutics - How Plus Therapeutics is shaping a focused capital-efficient pipeline - How their subsidiary @CNSideDx" [X Link](https://x.com/plustxinc/status/1996215890841583997) 2025-12-03T13:52Z 1527 followers, 3594 engagements "$PSTV announces three positive clinical data update presentations at the #WFNOS / @NeuroOnc's Annual Meeting. Key highlights below: - Cohort X data from multiple dose ReSPECT-#LeptomeningealMetastases (LM) #clinicaltrial showed no dosage limiting toxicity - ReSPECT-#Glioblastoma (GBM) trial of REYOBIQ as a novel therapeutic for recurrent #GBM demonstrated promising safety and efficacy signal supporting continued Phase X enrollment and investigation - MRI combined with SPECT imaging biomarkers effectively evaluate overall survival response with #REYOBIQ in recurrent GBM treatment and help" [X Link](https://x.com/plustxinc/status/1996564582467572042) 2025-12-04T12:57Z 1526 followers, 2774 engagements "$PSTV announceds new hires for @CNSideDx its wholly-owned subsidiary. Mr. Prem Gurnani joins as Senior Director of Lab Operations and Systems Implementation & Ms. Elaine Luckey joins as Director of Quality and Regulatory affairs. Read more: #CNSideDiagnostics #PSTV #CNSide" [X Link](https://x.com/plustxinc/status/1998373623401201984) 2025-12-09T12:46Z 1526 followers, 3135 engagements "Dr. Andrew Brenner will share a poster and oral presentation on $PSTV's ReSPECT phase X dose escalation #clinicaltrial results for #leptomeningealmetastases at @SABCSSanAntonio tomorrow morning. Learn more here: Learn more about our RESPECT-LM trial here: #SABCS25 #ClinicalTrials #PSTV @UTHealthSA #PlusTherapeutics #SABCS" [X Link](https://x.com/plustxinc/status/1999176680569762187) 2025-12-11T17:57Z 1526 followers, 2153 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@plustxinc Plus Therapeutics (Nasdaq: PSTV)
Plus Therapeutics recently announced a national coverage agreement with UnitedHealthcare, covering over XX million people in the US, for its CNSide cerebrospinal fluid tumor cell enumeration laboratory-developed test. This agreement is a significant development for the company's diagnostic test for leptomeningeal metastases. The company's CEO, Marc Hedrick, has been discussing this agreement in recent interviews.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXXXXX +4,106%
- X Months XXXXXXXXX +160,917%
- X Year XXXXXXXXX +104,507%
Mentions: X #
- X Month X -XX%
- X Months XX +417%
- X Year XX +85%
Followers: XXXXX #
- X Week XXXXX +0.99%
- X Month XXXXX +3.20%
- X Months XXXXX +100%
- X Year XXXXX +139%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence exchanges #2658
Social topic influence $pstv #2, $pstvs #1, ceo 25%, pstv 12.5%, san antonio 12.5%, poster 12.5%, abstract 12.5%, marc 12.5%, $6753t 12.5%, build a XXXX%
Top accounts mentioned or mentioned by @cnsidedx @uthealthsa @stocktwits @sabcssanantonio @katieeperry @humana @uhc @usfda @irat1onal @progresspotent1 @neurooncs @onlyxrp @matt034291601 @billcoconsult
Top Social Posts
Top posts by engagements in the last XX hours
"$PSTV's President and CEO Marc Hedrick MD recently spoke with @Stocktwits' @katieeperry on how #PSTV is harnessing the power of @CNSideDx to provide actionable insights for #oncology patients through highly personalized and effective treatment strategies. Dr. Hedrick discusses the capabilities of REYOBIQ in the ReSPECT #clinicaltrials and #CNSideDiagnostics' capabilities including our recent coverage partnerships with @Humana and @UHC goals to expand this coverage even further and more. Learn more about #CNSide here: Learn more about REYOBIQ here: Check out the full interview below:"
X Link 2025-12-01T21:22Z 1526 followers, 3585 engagements
"$PSTV announces that it has been granted lab licenses to provide the #CNSide Cerebrospinal Fluid Tumor Cell Enumeration lab developed test in California Rhode Island and Maryland. Full press release: Learn more about @CNSideDx:"
X Link 2025-12-11T12:50Z 1526 followers, 2981 engagements
"$PSTV announced it has completed a Type B meeting with the announced it has completed a Type B meeting with the @US_FDA to discuss its REYOBIQ clinical development plans for #leptomeningealmetastases including the design of a planned ReSPECT-LM pivotal or registrational trial. Read more here: About the ReSPECT-LM trial: #ClinicalTrial #PSTV #ClinicalTrials"
X Link 2025-11-24T12:42Z 1527 followers, 7142 engagements
"$PSTV announces the acceptance of an abstract for poster spotlight (with oral) presentation at the upcoming San Antonio Breast Cancer Symposium (#SABCS25) being held on December 9-12 2025 in San Antonio TX. Full press release here: @SABCSSanAntonio #SABCS @UTHealthSA"
X Link 2025-12-01T13:24Z 1527 followers, 2365 engagements
"#PlusTherapeutics momentum in central nervous system (CNS) oncology was highlighted when our President & CEO Marc Hedrick MD recently sat down with @irat1onal on the @ProgressPotent1 podcast. The discussion is a sharp look at where $PSTV is headed as we build a differentiated position in CNS #oncology. In under an hour Dr. Hedrick breaks down: - Why #leptomeningealmetastases (LM) and recurrent #glioblastoma (#GBM) represent some of the clearest opportunities for targeted #radiotherapeutics - How Plus Therapeutics is shaping a focused capital-efficient pipeline - How their subsidiary @CNSideDx"
X Link 2025-12-03T13:52Z 1527 followers, 3594 engagements
"$PSTV announces three positive clinical data update presentations at the #WFNOS / @NeuroOnc's Annual Meeting. Key highlights below: - Cohort X data from multiple dose ReSPECT-#LeptomeningealMetastases (LM) #clinicaltrial showed no dosage limiting toxicity - ReSPECT-#Glioblastoma (GBM) trial of REYOBIQ as a novel therapeutic for recurrent #GBM demonstrated promising safety and efficacy signal supporting continued Phase X enrollment and investigation - MRI combined with SPECT imaging biomarkers effectively evaluate overall survival response with #REYOBIQ in recurrent GBM treatment and help"
X Link 2025-12-04T12:57Z 1526 followers, 2774 engagements
"$PSTV announceds new hires for @CNSideDx its wholly-owned subsidiary. Mr. Prem Gurnani joins as Senior Director of Lab Operations and Systems Implementation & Ms. Elaine Luckey joins as Director of Quality and Regulatory affairs. Read more: #CNSideDiagnostics #PSTV #CNSide"
X Link 2025-12-09T12:46Z 1526 followers, 3135 engagements
"Dr. Andrew Brenner will share a poster and oral presentation on $PSTV's ReSPECT phase X dose escalation #clinicaltrial results for #leptomeningealmetastases at @SABCSSanAntonio tomorrow morning. Learn more here: Learn more about our RESPECT-LM trial here: #SABCS25 #ClinicalTrials #PSTV @UTHealthSA #PlusTherapeutics #SABCS"
X Link 2025-12-11T17:57Z 1526 followers, 2153 engagements